## Abstract The purpose of this study is to evaluate the real‐world dose utilization of Dysport and BOTOX for cervical dystonia and blepharospasm. Six investigational sites (five countries) were identified. Investigators abstracted utilization data for patients who received Dysport before switching
Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study
✍ Scribed by Albert Marchetti; Raf Magar; Leslie Findley; Jan P. Larsen; Zvezdan Pirtosek; Evžen Růžička; Robert Jech; Jaroslaw Sławek; Fayyaz Ahmed
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 34 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The original article to which this Erratum refers has been published in Movement DisordersMov Disord (2005) 20 (8) 937–934. © 2005 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The geste antagoniste (GA), a relatively common feature of adult‐onset primary dystonia, has been systematically evaluated only in cervical dystonia, but it is still unclear whether its frequency and phenomenology differ among the various forms of focal dystonia. We analysed the frequen
## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei
## Abstract The Brazilian domestic debt has posed two challenges to policy‐makers: it has grown very fast and its maturity is extremely short. This has prompted fears that a default or a compulsory lengthening scheme would be imposed. Here, we analyse the domestic public debt management experience